Nationwide Evidence-Based Treatment

Prescription Drug Addiction Treatment

Medications prescribed by a doctor can still lead to severe physical addiction. The line between medical use and dependency is easy to cross without even realizing it. Stopping abruptly can trigger dangerous physical withdrawal and intense anxiety. We offer a safe clinical path to step down from these medications gradually. Let us guide you back to a life free from prescription reliance.

Verify Insurance Coverage
Call (302) 555-1234

Confidential. Free assessment. Most insurance accepted.

Nationwide Evidence-Based Treatment

Prescription Drug Addiction Treatment

Medications prescribed by a doctor can still lead to severe physical addiction. The line between medical use and dependency is easy to cross without even realizing it. Stopping abruptly can trigger dangerous physical withdrawal and intense anxiety. We offer a safe clinical path to step down from these medications gradually. Let us guide you back to a life free from prescription reliance.

Verify Insurance Coverage
Call (302) 555-1234
  • Available 24/7
  • HIPAA Compliant
  • No Obligation

Confidential. Free assessment. Most insurance accepted.

15+

Years of Service

5000+

Lives Transformed

92%

Completion Rate

24/7

Support Availiable

Evidence-Based

Clinical Protocols
NIDA-aligned treatment approaches

Dual Diagnosis

Expertise
Integrated mental health & addiction care

Individualized

Treatment Planning
Tailored to each clinical profile

Nationwide

Care Network
Facilities across the United States

Prescription Drug Use Disorder

Prescription drug use disorder – commonly referred to as prescription drug addiction – is a chronic, relapsing brain condition in which an individual continues to use a prescription medication compulsively despite experiencing significant harm. According to the National Institute on Drug Abuse (NIDA), addiction involves fundamental changes to brain structure and function that affect decision-making, impulse control, and reward processing.

A prescription drug use disorder can develop even when medications are initially taken as prescribed. Certain medications – due to their mechanism of action – carry a risk of physical dependence with continued use. Dependence, while distinct from addiction, may precede the loss of control that characterizes a full use disorder.

The National Institutes of Health (NIH) characterizes substance use disorders as a spectrum of severity. Early identification and professional intervention significantly improve outcomes across all points on that spectrum.

Prescription drug use disorder does not reflect a moral failing or character weakness. It is a recognized medical condition with established biological, environmental, and developmental risk factors.

How Dependence Develops

Repeated exposure alters the brain’s dopamine and reward pathways
Tolerance develops, requiring higher amounts to achieve the same effect
Physical dependence means the body adapts to the substance’s presence
Withdrawal symptoms emerge when use is reduced or stopped
Loss of control over use despite consequences defines addiction

Diagnostic Classification

The DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders) classifies prescription drug use disorder under the broader category of Substance Use Disorders, evaluated across 11 clinical criteria ranging from mild to severe.

Recognizing the Signs

Signs of Meth Addiction

Recognizing the signs of methamphetamine use disorder can help individuals and their loved ones seek timely, appropriate support.

Behavioral Signs

  • Taking medication in higher amounts or more frequently than prescribed
  • Seeking prescriptions from multiple healthcare providers
  • Increasing preoccupation with obtaining or using the medication
  • Withdrawing from social, occupational, or recreational activities
  • Continuing use despite awareness of harm to health or relationships
  • Spending significant time obtaining, using, or recovering from the substance

Physical Signs

  • Unexplained drowsiness, sedation, or impaired coordination
  • Hyperactivity, restlessness, or reduced appetite
  • Disrupted sleep patterns – insomnia or excessive sedation
  • Nausea, gastrointestinal disturbances, or headaches
  • Withdrawal symptoms when attempting to reduce or stop use
  • Unexplained changes in weight or physical appearance

Psychological Effects

  • Increased anxiety, agitation, or irritability between doses
  • Depressive episodes or persistent low mood
  • Cognitive difficulties – impaired concentration or memory
  • Paranoia or heightened sensitivity to environmental stimuli
  • Using the medication to manage emotional distress rather than the original medical indication

Our confidential self-assessment can help provide a clinical framework for understanding your situation. Results are private and do not constitute a diagnosis.

Take a Confidential self-assesment

Categories of Prescription Drugs Associated with Addiction

Three broad pharmacological categories of prescription medications carry recognized potential for misuse and the development of a substance use disorder.

Opioid Pain Relievers

Prescription opioids are a class of analgesics used to manage moderate to severe pain. They act on opioid receptors in the brain and central nervous system, producing pain relief alongside significant euphoric effects that contribute to their high addiction potential.


The CDC identifies prescription opioids as a primary driver of the ongoing opioid overdose crisis. Misuse includes taking them in larger amounts than prescribed, using them without a prescription, or using them to achieve euphoria rather than manage pain.

Learn about opioid addiction Fentanyl: Risks and treatment

Central Nervous System (CNS) Depressants

CNS depressants are a class of medications that slow brain activity, prescribed for conditions including anxiety disorders, panic disorder, insomnia, and seizure disorders. This category includes benzodiazepines and certain sedative-hypnotic agents.


Physical dependence on CNS depressants can develop relatively quickly, even at prescribed doses. Withdrawal from this class of medication should always be managed under medical supervision, as unsupported cessation carries serious health risks

Note: This information is educational. For specific guidance on your medications, consult your prescribing physician.

Prescription Stimulants

Prescription stimulants are primarily prescribed for attention-deficit/hyperactivity disorder (ADHD) and certain sleep disorders. They increase dopamine and norepinephrine activity in the brain, improving focus and alertness when used as prescribed.


According to the FDA, stimulants have a high potential for misuse and are classified as controlled substances. Misuse – particularly at higher frequencies or amounts than prescribed – can lead to dependence and significant cardiovascular strain.

Clinical information only. Specific medications are discussed only in a general pharmacological context.

Health Risks of Prescription Drug Misuse

Prescription drug misuse carries serious, sometimes life-threatening medical risks. The following information is provided to educate individuals and families about the clinical consequences of misuse. This is not an exhaustive clinical review.

Respiratory Depression

Opioid medications suppress the brain’s respiratory centers. Misuse – or combining opioids with other CNS depressants – can cause dangerously slowed or stopped breathing. This is the primary mechanism of opioid overdose fatality. The CDC reports tens of thousands of opioid-related overdose deaths annually in the United States.

Cardiovascular Strain

Misuse of prescription stimulants places significant strain on the cardiovascular system, including elevated heart rate, increased blood pressure, and heightened risk of cardiac events. Individuals with pre-existing cardiovascular conditions face compounded risk, as documented in FDA prescribing guidelines.

Seizure Risk

Abrupt discontinuation of CNS depressants after physical dependence has developed carries a risk of seizures, which can be life-threatening. Medical supervision is essential when reducing or stopping these medications. This risk underscores the importance of medically managed withdrawal protocols.

Organ Damage

Prolonged misuse of certain prescription medications can cause hepatotoxicity (liver damage) and nephrotoxicity (kidney damage), particularly when medications containing acetaminophen are taken in excess. Long-term systemic effects may affect multiple organ systems.

Withdrawal Syndrome

Chronic misuse alters neural pathways governing reward, motivation, memory, and executive function. Cognitive impairments including reduced processing speed, impaired memory consolidation, and diminished impulse control may persist beyond cessation of use and often benefit from targeted therapeutic intervention.

Neurological Effects

Chronic misuse alters neural pathways governing reward, motivation, memory, and executive function. Cognitive impairments including reduced processing speed, impaired memory consolidation, and diminished impulse control may persist beyond cessation of use and often benefit from targeted therapeutic intervention.

If overdose is suspected, call 911 immediately.

Overdose is a life-threatening medical emergency. Signs may include unresponsiveness, slow or absent breathing, blue-tinted lips or fingertips, pinpoint pupils, or loss of consciousness. Naloxone (a medication that can reverse opioid overdose) is available without a prescription in many states.
Do not leave the person alone. Place them in the recovery position if unconscious and breathing. Follow emergency dispatcher instructions until medical personnel arrive.

Treatment Programs & Services

We offer a full continuum of care, from initial stabilization through long-term recovery support. Each program is guided by ASAM placement criteria and current clinical best practices.

Inpatient Rehabilitation

Structured, residential clinical care

24-hour supervised care in a medically managed residential environment for individuals with moderate to severe substance use disorders requiring intensive clinical support.

  • Appropriate for: Severe addiction, medical detox needs, unstable home environment
  • Duration: Typically 30–90 days
  • Components: Medical supervision, individual & group therapy, medication management
Learn More

Outpatient Programs

Flexible therapy-based care

Flexible, therapy-based care that allows individuals to continue living at home while receiving structured clinical support and evidence-based treatment services.

  • Appropriate for: Mild to moderate symptoms, strong support system, step-down from inpatient
  • Duration: 3-12 months
  • Components: Individual therapy, group sessions, relapse prevention, family counseling
Learn More

Dual-Diagnosis Treatment

Integrated mental health + addiction care

Integrated treatment for co-occurring substance use and mental health disorders. Research consistently demonstrates that simultaneous treatment of both conditions improves outcomes.

  • Appropriate for: Co-occurring depression, anxiety, PTSD, bipolar disorder with substance use
  • Duration: Varies by clinical assessment
  • Components: Psychiatric evaluation, integrated therapy, medication management
Learn More

Medication-Assisted Treatment

FDA-approved medications + therapy

FDA-approved medications combined with counseling and behavioral therapies to provide a whole-patient approach to substance use disorder treatment.

  • Appropriate for: Opioid use disorder, alcohol use disorder, withdrawal management
  • Duration: Individualized; may be ongoing
  • Components: Buprenorphine, methadone, or naltrexone combined with behavioral counseling
Learn More

Medical Detoxification

Safe withdrawal + 24/7 clinical supervision

Medical detox provides a safe, monitored environment to manage withdrawal symptoms as the body clears itself of substances. This process minimizes physical risks and ensures patient comfort before transitioning to ongoing therapy.

  • Appropriate for: Severe alcohol, opioid, or prescription drug dependence requiring medical intervention
  • Duration: 3 to 10 days, depending on the substance and severity
  • Components: 24/7 medical monitoring, medication-assisted treatment, withdrawal symptom management, transition planning
Learn More

When to Seek Help

If you or someone you care about is experiencing any of the following, it may be appropriate to consult with a licensed treatment professional.

  • Escalating frequency or quantity of use
  • Physical health complications related to use
  • Strained or damaged relationships
  • Difficulty maintaining employment
  • Previous attempts to quit without success
  • Co-occurring mental health symptoms

The SAMHSA National Helpline (1-800-662-4357) provides free, confidential, 24/7 referrals and information. You can also take a confidential self-assessment to better understand the situation.

When to Seek Help

If you or someone you care about is experiencing any of the following, it may be appropriate to consult with a licensed treatment professional.

  • Escalating frequency or quantity of use
  • Physical health complications related to use
  • Strained or damaged relationships
  • Difficulty maintaining employment
  • Previous attempts to quit without success
  • Co-occurring mental health symptoms

The SAMHSA National Helpline (1-800-662-4357) provides free, confidential, 24/7 referrals and information. You can also take a confidential self-assessment to better understand the situation.

Insurance Coverage & Financial Options

The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover substance use disorder treatment at parity with medical and surgical care. Beacon Addiction Care accepts most major insurance providers.

Our financial counselors work with each patient and family to maximize insurance benefits, explain out-of-pocket costs, and identify additional resources including state-funded programs and sliding-scale options.

Contact Us Today (302) 555-1234

Accepted Insurance Providers

  • Aetna
  • Cigna
  • Humana
  • Medicaid
  • TRICARE
  • BlueCross BlueShield
  • UnitedHealthcare
  • Kaiser Permanente
  • Medicare
  • Anthem

Don’t see your provider? Contact us – we work with most plans.

Frequently Asked Questions

Answers about addiction, withdrawal, and treatment.

Prescription drug addiction – clinically referred to as prescription drug use disorder – is a chronic, relapsing condition characterized by compulsive drug-seeking behavior despite harmful consequences. It occurs when the brain’s reward circuitry is altered by repeated exposure to a substance, leading to physical dependence, tolerance, and loss of control over use. According to the National Institute on Drug Abuse (NIDA), addiction involves both physical and psychological components that require professional treatment.

Yes. Even when taken as directed, certain medications – particularly opioid pain relievers, CNS depressants, and prescription stimulants – carry a risk of physical dependence. Dependence can develop in the absence of misuse, particularly with long-term use. If dependence progresses to compulsive use, loss of control, or continued use despite harm, it meets diagnostic criteria for a substance use disorder. The FDA and NIDA recommend that patients and prescribers discuss these risks openly.

Warning signs include taking medication in higher amounts or more frequently than prescribed, seeking prescriptions from multiple providers, experiencing withdrawal symptoms when not taking the medication, mood and behavioral changes, neglecting responsibilities, and continued use despite negative consequences. Physical signs may include changes in sleep, unexplained drowsiness, or agitation. If you are concerned, speaking with a healthcare professional is recommended.

A prescription does not eliminate the potential for harm or addiction. When used outside of a prescribing physician’s guidance, prescription drugs carry serious risks comparable to illicit substances. Opioid pain relievers can cause life-threatening respiratory depression. The CDC identifies prescription opioids as a significant contributor to the overdose crisis. Clinical risks are real regardless of whether a substance is legally prescribed.

Many private insurance plans, Medicaid, and Medicare cover substance use disorder treatment under the Mental Health Parity and Addiction Equity Act (MHPAEA). Coverage typically includes detoxification, inpatient rehabilitation, outpatient programs, and medication-assisted treatment (MAT). Specific benefits vary by plan. Beacon Addiction Care’s specialists can help verify your individual coverage.

Treatment duration varies based on the type of substance, duration and severity of use, co-occurring mental health conditions, and personal circumstances. NIDA guidelines indicate that longer engagement in treatment is associated with better outcomes. Programs may range from structured 30-day residential stays to extended outpatient care spanning several months. A clinical assessment is the most reliable way to determine the appropriate level and duration of care.

Dual diagnosis treatment addresses both a substance use disorder and a co-occurring mental health condition simultaneously. Research shows integrated treatment produces better outcomes than treating each in isolation. Common co-occurring conditions include depression, anxiety disorders, PTSD, and bipolar disorder. Dual diagnosis programs employ psychiatrists, licensed counselors, and addiction medicine specialists working collaboratively.

Medication-assisted treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. For opioid use disorder, MAT may include medications that reduce cravings and withdrawal symptoms. SAMHSA recognizes MAT as a gold-standard component of comprehensive addiction treatment. It is a clinical tool used within a broader therapeutic framework, not a standalone solution.

Reviewed by Dr. Emily Rodriguez

Specializes in trauma-informed care | CBT, DBT, EMDR
Last Updated: February 2026

Sources & Citations:

  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • American Psychiatric Association (APA)

Reviewed by Dr. Emily Rodriguez

Specializes in trauma-informed care | CBT, DBT, EMDR
Last Updated: February 2026

Sources & Citations:

  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • American Psychiatric Association (APA)

Medical Disclaimer: The information on this page is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment options.

Confidentiality Notice: Beacon Addiction Care is committed to protecting your privacy. All communications are handled in accordance with HIPAA (Health Insurance Portability and Accountability Act) regulations and 42 CFR Part 2 federal confidentiality requirements for substance use disorder treatment records.

Beacon Addiction Care does not guarantee specific treatment outcomes. Individual results vary based on the nature and severity of the substance use disorder, co-occurring conditions, and adherence to the treatment plan.

Professional Treatment Can Support a Safe Path Forward

Recovery from prescription drug addiction is achievable with the right clinical support. Beacon Addiction Care connects individuals and families with evidence-based treatment programs nationwide. Speak confidentially with a care specialist today – all inquiries are HIPAA protected.
Schedule a Consultation (302) 555-1234

All inquiries are confidential and HIPAA-compliant.